Laboratory markers of toxoplasmosis in heart recipients

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND. The number of organ transplantation surgeries is growing every year, including heart transplantion. The full spectrum of infections in heart transplant recipients is not well understood. One of the infectious agents that is particularly difficult to recognize is Toxoplasma gondii (T. gondii).

AIM: This work determines the informative value of detecting laboratory markers of toxoplasmosis in patients after heart transplantation to identify active forms of invasion.

MATERIALS AND METHODS: This investigation studied 121 heart recipients (95 men and 26 women) at different times after transplantation (several days to 12 years). Markers of Toxoplasma invasion were determined in blood sera, namely antibodies of the IgG, IgM, and IgA classes to T. gondii, avidity index of IgG antibodies to T. gondii, and DNA of the pathogen.

RESULTS: In 60 patients (49.6±4.5%) after heart transplantation, markers of Toxoplasma invasion were identified. In 20 (16.5±3.6%) cases, markers of active invasion were revealed, namely IgM and IgA antibodies to T. gondii in six and 11 patients, respectively, low-grade IgG antibodies to T. gondii in three patients, and DNA of the pathogen in two cases. Based on the totality of studies, it was determined that the disease activity in 75% of cases was due to its reactivation, whereas in the other cases, it was a recent infection. Laboratory signs of toxoplasmosis reactivation occurred mainly during the first year after transplantation, which was probably associated with the intensity of immunosuppressive therapy.

CONCLUSIONS: It was revealed that the most compelling studies indicating early signs of toxoplasmosis reactivation include detection of IgA antibodies to T. gondii and DNA of the pathogen. Further joint research is required by clinicians, epidemiologists, and laboratory diagnostics specialists to study the aspects of toxoplasmosis and disease diagnostics and preventionin patients after heart transplantation.

About the authors

Evgeniya V. Abbazova

N.F. Gamaleya Federal Research Center of Epidemiology and Microbiology

Author for correspondence.
Email: janifer@inbox.ru
ORCID iD: 0000-0001-6328-8142

MD, Cand. Sci. (Med.)

Russian Federation, Moscow

Dmitriy B. Goncharov

N.F. Gamaleya Federal Research Center of Epidemiology and Microbiology

Email: goncharov_toxo@mail.ru
ORCID iD: 0000-0002-0250-4902

MD, Cand. Sci. (Biol.)

Russian Federation, Moscow

Elvira A. Domonova

Central Research Institute of Epidemiology

Email: elvira.domonova@pcr.ms
ORCID iD: 0000-0001-8262-3938

MD, Cand. Sci. (Biol.)

Russian Federation, Moscow

Olga Yu. Silveystrova

Central Research Institute of Epidemiology

Email: olga.silveystrova@pcr.ms
ORCID iD: 0000-0001-8412-9765
Russian Federation, Moscow

Vasilisa A. Kovaleva

N.F. Gamaleya Federal Research Center of Epidemiology and Microbiology

Email: vasilisa.Kovaliova@gmail.com
ORCID iD: 0000-0003-0215-4938
Russian Federation, Moscow

Irina V. Titova

N.F. Gamaleya Federal Research Center of Epidemiology and Microbiology

Email: i-titova-54@yandex.ru

MD, Cand. Sci. (Med.)

Russian Federation, Moscow

Vyacheslav M. Zakharevich

V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs

Email: zaharslava@yandex.ru
ORCID iD: 0000-0002-1090-6901

MD, Dr. Sci. (Med.), Professor

Russian Federation, Moscow

Viktoriya G. Kormilitsyna

V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs

Email: v16k@rambler.ru
ORCID iD: 0000-0002-6475-3904
Russian Federation, Moscow

Ilhomhodzha I. Muminov

V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs

Email: scorpion_if@mail.ru
ORCID iD: 0000-0002-7509-1440

MD, Cand. Sci. (Med.)

Russian Federation, Moscow

Nadezhda N. Koloskova

V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs

Email: nkrasotka@mail.ru
ORCID iD: 0000-0002-5819-9046

MD, Dr. Sci. (Med.)

Russian Federation, Moscow

Timur A. Khalilulin

V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs

Email: timur-medicina@list.ru
ORCID iD: 0000-0002-6068-4462

MD, Cand. Sci. (Med.)

Russian Federation, Moscow

Nina I. Gabrielyan

V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs

Email: labgso@mail.ru
ORCID iD: 0000-0003-1941-8311

MD, Dr. Sci. (Med.)

Russian Federation, Moscow

References

  1. Got'e SV, Shevchenko AO, Poptsov VN, et al. Opyt 800 transplantatsiy serdtsa v nmits transplantologii i iskusstvennykh organov im. akad. V.I. Shumakova. Russian journal of transplantology and artificial organs. 2017;19(S):52–53. (In Russ).
  2. Derouin F, Pelloux H, Parasitology ESGoC. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008;14(12):1089–1101.
  3. Barbukhatti KO, Kosmacheva ED, Kolodina MV, et al. 5-year experience of orthotopic heart transplantation in the Krasnodar region. Russian Journal of Transplantology and Artificial Organs. 2015;17(2):80–84. (In Russ).
  4. Poptsov VN, Saitgareev RSh, Shumakov DV, et al. Ortotopicheskaya transplantatsiya serdtsa U retsipientov 60 let i starshe. Russian Journal of Transplantology and Artificial Organs. 2016;18(S):28. (In Russ).
  5. Simonenko MA, Nikolaev GV, Fedotov PA, et al. Infektsionnye oslozhneniya v rannem periode posle transplantatsii serdtsa. Russian Journal of Transplantology and Artificial Organs. 2019;21(S):37. (In Russ).
  6. Spiridonov SV, Ostrovskiy YP, Valentyukevich AV, et al. Rezul'taty transplantatsii serdtsa v Respublike Belarus'. Russian Journal of Transplantology and Artificial Organs. 2019;21(S):46. (In Russ).
  7. Chernyavskiy AM, Doronin DV, Fomichev AV, et al. 10-year heart transplantation experience in Novosibirsk. Russian Journal of Transplantology and Artificial Organs. 2018;20(1):23–31. (In Russ). doi: 10.15825/1995-1191-2018-1-23-31
  8. Simonenko MA, Fedotov PA, Sazonova YV, et al. Oslozhneniya v otdalennom periode posle transplantatsii serdtsa. Russian Journal of Transplantology and Artificial Organs.2018;20(S1):38–39. (In Russ).
  9. Gubareva EV, Goncharov DB, Kobets NV, et al. Approaches to diagnostics and prophylaxis of toxoplasmosis in HIV-infected patients. Epidemiology and Vaccinal Prevention. 2010;(4):60–65.
  10. Robert-Gangneux F, Darde ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25(2):264–296. doi: 10.1128/CMR.05013-11
  11. Khurana S, Batra N. Toxoplasmosis in organ transplant recipients: Evaluation, implication, and prevention. Trop Parasitol. 2016;6(2):123–128. doi: 10.4103/2229-5070.190814
  12. Robert-Gangneux F, Meroni V, Dupont D, et al. Toxoplasmosis in Transplant Recipients, Europe, 2010–2014. Emerg Infect Dis. 2018;24(8):1497–1504. doi: 10.3201/eid2408.180045
  13. Wolyniec W, Sulima M, Renke M, Debska-Slizien A. Parasitic Infections Associated with Unfavourable Outcomes in Transplant Recipients. Medicina (Kaunas). 2018;54(2):27. doi: 10.3390/medicina54020027
  14. Goncharov DB, Gabrielyan NI, Abbazova EV, et al. Toxoplasmosis as an opportunistic protozoan infestation and its significance in transplantation. Russian Journal of Transplantology and Artificial Organs. 2015;17(4):95–103. (In Russ).
  15. Dard C, Marty P, Brenier-Pinchart MP, et al. Management of toxoplasmosis in transplant recipients: an update. Expert Rev Anti Infect Ther. 2018;16(6):447–460. doi: 10.1080/14787210.2018.1483721
  16. Fernandez-Sabe N, Cervera C, Farinas MC, et al. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. Clin Infect Dis. 2012;54(3):355–361. doi: 10.1093/cid/cir806
  17. Abbazova EV, Goncharov DB, Ievleva ES, et al. Monitoring toksoplazmennoy invazii v Moskve. In: Materialy XI Ezhegodnogo Vserossiyskogo Kongressa po infektsionnym boleznyam s mezhdunarodnym uchastiem (Moskva, 1–3 aprelya 2019g.). Moscow; 2019. P:5. (In Russ).
  18. Patrat-Delon S, Gangneux JP, Lavoue S, et al. Correlation of parasite load determined by quantitative PCR to clinical outcome in a heart transplant patient with disseminated toxoplasmosis. J Clin Microbiol. 2010;48(7):2541–2545. doi: 10.1128/JCM.00252-10

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. The identification of toxoplasmosis markers in patients after orthotopic heart transplantation less than and more than one year ago.

Download (140KB)
3. Fig. 2. The detection of specific IgA antibodies in patients infected with T. gondii at different times after orthotopic heart transplantation (OTHT): а — in patients with OTHT less than one year ago; b — in patients with OTHT more than one year ago.

Download (171KB)

Copyright (c) 2021 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies